(EMAILWIRE.COM, February 06, 2019 ) Over the last few years, the tumor ablation market has witnessed significant advancements in terms of the development and commercialization of novel tumor ablation products.

A number of factors such as technological advancements in the field of tumor ablation focused on enhancing effectiveness and safety of the treatment, rising demand of minimal invasive tumor ablation techniques, increasing prevalence of cancer across the globe, and growing public-private initiatives and funding to support R&D activities in tumor ablation are propelling the growth of the market.

In 2016, North America is expected to hold the largest share of the global tumor ablation market. However, developing Asia-Pacific countries such as China and India are emerging as new revenue-generating destinations for prominent market players. Growing prevalence of cancer along with rising elderly population, increasing medical tourism, and evolving regulatory scenario are expected to offer high growth opportunities in the Asia-Pacific region.

Read More Details | Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142550258

The surgical mode segment is expected to hold largest share of tumor ablation market in 2016. Increasing preference for minimally invasive surgical procedures in mature markets (such as U.S., Italy, and Germany) to treat various cancers, growing awareness among surgeons about the benefits of surgical ablation, and growing proportion of cancer patients undergoing minimally invasive surgeries (owing to their ineligibility or reluctance to undergo open surgery) are key drivers for this market segment.

Microwave tumor ablation offers high growth opportunities for market players. This technology is outpacing other tumor ablation technologies due to its additional therapeutic benefits such as faster heat-generation (which reduces the susceptibility to damage to surrounding organs and gives opportunity to ablate larger tumors), lower heat-sink effect (that results in destruction of surrounding healthy tissue), and better safety & efficacy profile.

Companies such as Angiodynamics, Inc. (U.S.), Boston Scientific Corporation (U.S.), Galil Medical, Inc. (U.S.), EDAP TMS S.A. (France), Healthtronics, Inc. (U.S.), Medtronic, Plc (U.S.), Mermaid Medical, Inc. (Denmark), Mesonix, Inc. (U.S.), Neuwave Medical, Inc. (U.S.), and Sonacare Medical, LLC (U.S.) are investing in this high-growth market to enhance profits and increase their shares in the tumor ablation market.

Get the Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=142550258

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com